LUCIUS 卢修斯 托法替尼 Tofacitinib类风湿性关节炎 银屑病关节炎 溃疡性结肠炎

托法替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Tofacitinib

老挝国家食药监局批准上市
老挝国家药检所检测认证
类风湿性关节炎

Compositioa:

Each film-coated tablet contains Tofacitimib citrate
mg equivalent to Tofacitimib.

LUCiUS
PHARMACEUTICALS

银屑病关节炎

LuciTofa is a Janus kinase (JAK)ihibitor.
.Rheumatoid Arthritis: LueiTofs is indie
ucilofa is 10dieated for the
paents with moderately

sevefely attive fietmatold arfritis who have had an

溃疡性结肠炎

inadequate response or intolerance to methotrexate

LuciTofa

.Psoriatic Artartis: LuciTofa is idicated for the
treatment of adult patients with active osoratic
arthritis who have had an inadequate response or

Tofacitinib Tablets

iatolerance to methotrexate or other disease
modifying antirheumatie druss (DMARDsI.
Dosage and Use:

5mg

Kecommended Dosage
Rhemataid A rthritie and Paotiatie Arthritis: 2 tng
Kaeumatond Artritis and Fsora
twice daily. Recommended dosage in patients win

FDA批准

moderate and severe renal inparment or moderale
hepatic impairment is LuciTofa 5 me once daily.

Rx only

Sforage: in a dry place and store at 20'C to 25 C.
Warsing:
Keep medicine out of reach of Children Do not
administer LuciTofa during Pregnancy and Lactation.
PLEASE SEE PACKAGEINSERT
Manufactured and Marketed by
UCIUS

权威认证

Thongmang village, Xaythany distr
Warning: To be sold by retal on prescriotion
e peled physicians only, and as direeted

30 Tablets

口碑质量

适应症:
1、类风湿性关节炎:适用于治疗对甲氨蝶呤反应不足或不耐受的中度
至重度活动性类风湿性关节炎成年患者。可作为单一疗法使用,也可与
甲氨蝶呤或其他非生物抗风湿药物(DMARD)联合使用。
2、银屑病关节炎:适用于治疗对甲氨蝶呤或其他抗风湿药物(DMARD)
反应不足或不耐受的中度至重度活动性银屑病关节炎成年患者。
3、溃疡性结肠炎:适用于治疗中度至重度活动性溃疡性结肠炎(UC)成
年患者。
推荐剂量:
1、类风湿性关节炎:每日两次,每次5mg;
2、银屑病关节炎:每日两次,每次5mg,与非生物DMARD联合使用;
3、溃疡性结肠炎:每日两次,每次10mg,至少持续8周。